CAMK2G and prostate cancer: In addition, we did not see a decrease in β-catenin protein expression and the activity of CaMKII was found to increase in prostate cancer cell lines, indicating that Wnt/Ca2+ pathway was likely to be operative via CaMKII in prostate cancer.